AMLX three-lens brief
Evidence-based stock research on AMLX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +2.88% yesterday. · Negative free cash flow last quarterly (-$80.52M).
- Moved +2.88% yesterday.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Outperforming SPY by 9.6pp over 30 days.
- P/E of 2.5 — trading at a value multiple.
- Analyst mean target $43.00 — 35% above current (11 analysts).
AMLX closed at $31.80 (+2.88%) as of 2026-11-12. Market cap: $4.09B. P/E (trailing) 2.5. Price is above the 50-day MA and above the 200-day MA. Positives: moved +2.88% yesterday.; 50-day MA above 200-day MA (golden-cross regime); price above both.. Concerns: negative free cash flow last quarterly (-$80.52M).. Last quarter: net income -$45.49M, free cash flow -$80.52M.
Why three lenses on AMLX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMLX across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AMLX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMLX brief"></iframe>